Skip to main content

Advertisement

SpringerLink
Log in

Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green (ICG) fluorescence real-time imaging in breast cancer

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

A new sensitive fluorescence imaging system was developed for the real-time identification of sentinel lymph nodes (SLNs) in patients with early breast cancer. The purpose of this study was to evaluate the utility of a color charge-coupled device camera system for the intraoperative detection of SLNs and to determine its clinical efficacy and sensitivity in patients with operable breast cancer. We assessed a total of 168 patients diagnosed with or suspected of having early-stage breast cancer without metastasis in SLNs. The intraoperative detection of SLNs was performed using the conventional Indigo Carmine dye (indigotindisulfonate sodium) technique combined with a new Indocyanine green (ICG) imaging system (HyperEye Medical System: HEMS, MIZUHO IKAKOGYO, Japan) to map SLNs, in which the lymphatic vessels and SLNs were visualized transcutaneously with illuminating ICG fluorescence. Between January 2012 and May 2013, SLNs were successfully identified in all 168 patients (detection rate: 100 %). By histopathology, the sensitivity was 93.8 % for the detection of the metastatic involvement of SLNs (15 of 16 nodal-positive patients). After a median follow-up of 30.5 months, none of the patients presented with axillary recurrence. These results suggest that the HEMS imaging system is a feasible and effective method for the detection of SLNs in breast cancer. Furthermore, the HEMS device permitted the transcutaneous visualization of lymphatic vessels under light conditions, thus facilitating the identification and detection of SLNs without affecting the surgical procedure, together with a high sensitivity and specificity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lyman GH, Temin S, Edge SB et al (2014) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 32(13):1365–1383

    Article  PubMed  Google Scholar 

  2. Galimberti V, Manika A, Maisonneuve P et al (2014) Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease. Eur J Surg Oncol 40(10):1203–1208

    Article  CAS  PubMed  Google Scholar 

  3. Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546–553

    Article  PubMed  Google Scholar 

  4. Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98(9):599–609

    Article  PubMed  Google Scholar 

  5. Wilke LG, McCall LM, Posther KE et al (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13(4):491–500

    Article  PubMed  Google Scholar 

  6. Fleissig A, Fallowfield LJ, Langridge CI et al (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95(3):279–293

    Article  PubMed  Google Scholar 

  7. Temple LK, Baron R, Cody HS et al (2002) Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 9(7):654–662

    Article  PubMed  Google Scholar 

  8. De Gournay E, Guyomard A, Coutant C et al (2013) Impact of sentinel node biopsy on long-term quality of life in breast cancer patients. Br J Cancer 109(11):2783–2791

    Article  PubMed Central  PubMed  Google Scholar 

  9. Ram R, Singh J, McCaig E (2014) Sentinel node biopsy alone versus completion axillary node dissection in node positive breast cancer: systematic review and meta-analysis. Int J Breast Cancer 2014:513780

    Article  PubMed Central  PubMed  Google Scholar 

  10. Verbelen H, Gebruers N, Eeckhout FM et al (2014) Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review. Breast Cancer Res Treat 144(1):21–31

    Article  PubMed  Google Scholar 

  11. Sardi A, Spiegler E, Colandrea J et al (2002) The benefit of using two techniques for sentinel lymph node mapping in breast cancer. Am Surg 68(1):24–28

    PubMed  Google Scholar 

  12. Stratmann SL, McCarty TM, Kuhn JA (1999) Radiation safety with breast sentinel node biopsy. Am J Surg 178(6):454–457

    Article  CAS  PubMed  Google Scholar 

  13. Rutgers EJ (2005) Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol 31(6):568–576

    Article  PubMed  Google Scholar 

  14. van der Ploeg IM, Kroon BB, Antonini N et al (2008) Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration. Ann Surg Oncol 15(4):1025–1031

    Article  PubMed  Google Scholar 

  15. Bass SS, Lyman GH, McCann CR et al (1999) Lymphatic mapping and sentinel lymph node biopsy. Breast J 5(5):288–295

    Article  PubMed  Google Scholar 

  16. Sandrucci S, Casalegno PS, Percivale P et al (1999) Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures. Tumori 85(6):425–434

    CAS  PubMed  Google Scholar 

  17. Hirche C, Murawa D, Mohr Z et al (2010) ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 121(2):373–378

    Article  PubMed  Google Scholar 

  18. Abe H, Mori T, Umeda T, Tanaka M et al (2011) Indocyanine green fluorescence imaging system for sentinel lymph node biopsies in early breast cancer patients. Surg Today 41(2):197–202

    Article  CAS  PubMed  Google Scholar 

  19. Wishart GC, Loh SW, Jones L, Benson JR (2012) A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. Eur J Surg Oncol 38(8):651–656

    Article  CAS  PubMed  Google Scholar 

  20. Kitai T, Inomoto T, Miwa M, Shikayama T (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12(3):211–215

    Article  PubMed  Google Scholar 

  21. Sevick-Muraca EM, Sharma R, Rasmussen JC et al (2008) Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology 246(3):734–741

    Article  PubMed Central  PubMed  Google Scholar 

  22. Murawa D, Hirche C, Dresel S, Hunerbein M (2009) Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg 96(11):1289–1294

    Article  CAS  PubMed  Google Scholar 

  23. Morton DL, Bostick PJ (1999) Will the true sentinel node please stand? Ann Surg Oncol 6(1):12–14

    Article  CAS  PubMed  Google Scholar 

  24. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220(3):391–398; discussion 398–401

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Turner RR, Ollila DW, Krasne DL, Giuliano AE (1997) Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226(3):271–276

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS 3rd, Edge SB, Galper S et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703–7720

    Article  PubMed  Google Scholar 

  27. Vahrmeijer AL, Hutteman M, van der Vorst JR et al (2013) Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 10(9):507–518

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Schaafsma BE, Mieog JS, Hutteman M et al (2011) The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 104(3):323–332

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Handa T, Katare RG, Sasaguri S, Sato T (2009) Preliminary experience for the evaluation of the intraoperative graft patency with real color charge-coupled device camera system: an advanced device for simultaneous capturing of color and near-infrared images during coronary artery bypass graft. Interact Cardiovasc Thorac Surg 9(2):150–154

    Article  PubMed  Google Scholar 

  30. Handa T, Katare RG, Nishimori H et al (2010) New device for intraoperative graft assessment: HyperEye charge-coupled device camera system. Gen Thorac Cardiovasc Surg 58(2):68–77

    Article  PubMed  Google Scholar 

  31. Troyan SL, Kianzad V, Gibbs-Strauss SL et al (2009) The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 16(10):2943–2952

    Article  PubMed Central  PubMed  Google Scholar 

  32. Crane LM, Themelis G, Pleijhuis RG et al (2011) Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol 13(5):1043–1049

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This study was partially supported by research funding from the Japanese Society for the Promotion of Science.

Author information

Authors and Affiliations

  1. Department of Surgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan

    U. Toh, N. Iwakuma, M. Mishima, M. Okabe, S. Nakagawa & Y. Akagi

Authors
  1. U. Toh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Iwakuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Mishima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Okabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y. Akagi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U. Toh.

Ethics declarations

Conflict of interest

The authors do not have any conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toh, U., Iwakuma, N., Mishima, M. et al. Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green (ICG) fluorescence real-time imaging in breast cancer. Breast Cancer Res Treat 153, 337–344 (2015). https://doi.org/10.1007/s10549-015-3542-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-015-3542-9

Keywords

Search

Navigation